TELA Bio, Inc. (TELA) Return on equity 2019–2025
TELA Bio, Inc. (TELA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-615.1%FY2025 · since FY2019: -72.4% → -615.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -615.1% | -482.1 pp |
| FY2024 | -133.0% | +114.2 pp |
| FY2023 | -247.1% | +62.5 pp |
| FY2022 | -309.7% | -144.1 pp |
| FY2021 | -165.6% | -106.8 pp |
| FY2020 | -58.7% | +13.7 pp |
| FY2019 | -72.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Net marginTELA Gross profitTELA Gross marginTELA Operating incomeTELA Operating marginTELA Operating cash flowTELA Free cash flowTELA Capital expendituresTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Total liabilitiesTELA Shareholders’ equityTELA overview →